- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | OneMedNet schließt Datenvertrag für KI-gestützte Medikamentenentwicklung | - | Investing.com Deutsch | ||
| 31.08. | OneMedNet secures AI drug development data agreement | 1 | Investing.com | ||
| 31.08. | OneMedNet Corporation: OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company | 1 | GlobeNewswire (USA) | ||
| 29.07. | OneMedNet Stock Rallies 33% After Hours: Here's Why | 2 | Benzinga.com | ||
| 28.07. | OneMedNet Corporation: OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development | 1 | GlobeNewswire (USA) | ||
| 24.07. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | OneMedNet Corp - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| ONEMEDNET Aktie jetzt für 0€ handeln | |||||
| 01.07. | OneMedNet Corp - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 01.07. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | OneMedNet secures over $3M in bookings YTD, beating all of 2025 | 2 | Seeking Alpha | ||
| 10.06. | OneMedNet Corporation: OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025 | 1 | GlobeNewswire (USA) | ||
| 03.06. | OneMedNet Corporation: OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network | 1 | GlobeNewswire (USA) | ||
| 20.04. | OneMedNet Corp - 8-K, Current Report | - | SEC Filings | ||
| 06.04. | OneMedNet reports FY results | 1 | Seeking Alpha | ||
| 06.04. | OneMedNet meldet Umsatzwachstum von 329 % und reduziert Verbindlichkeiten um 74 % | 2 | Investing.com Deutsch | ||
| 06.04. | OneMedNet Corporation: OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | 420 | GlobeNewswire (Europe) | MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven... ► Artikel lesen | |
| 01.04. | Inka Health partners with OneMedNet for oncology data access | 27 | Investing.com | ||
| 01.04. | OneMedNet Corporation: OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | 347 | GlobeNewswire (Europe) | MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready... ► Artikel lesen | |
| 18.03. | OneMedNet Corporation: OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights | 769 | GlobeNewswire (Europe) | MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready... ► Artikel lesen | |
| 12.02. | OneMedNet Corporation: OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition | 662 | GlobeNewswire (Europe) | MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), today announced... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| HEALWELL AI | 0,495 | -1,88 % | Healwell AI Inc: Healwell AI to roll out Smart tools on Iowa HIE | ||
| SPINEWAY | 0,109 | -3,38 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,020 | 0,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update | Executed a development collaboration with Senlang Biotechnology to advance certain in vivo CAR-T product candidates, including TPST-4003, a CD7-targeted next-generation in vivo CAR-T, with first patient... ► Artikel lesen | |
| FRESENIUS | 43,295 | -0,77 % | AKTIEN IM FOKUS: Zinsanstieg birgt Gefahren für sichere Aktienhäfen | FRANKFURT (dpa-AFX) - Steigende Zinsen an den Kapitalmärkten haben zum Wochenbeginn die Aktienkurse von als sichere Anlagen geltenden Unternehmen belastet. Dazu zählen unter anderen die Immobilienwerte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,280 | +0,15 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,620 | -0,97 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 99,50 | 0,00 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| HEARTFLOW | 48,880 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,530 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,75 | +0,03 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| GERRESHEIMER | 29,840 | +5,52 % | PRESSESPIEGEL/Unternehmen: VOLKSWAGEN, BERTELSMANN, GERRESHEIMER, GLENCORE/RADIANT, AIRBUS | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
VOLKSWAGEN - Im Machtkampf um das nächste Sanierungspaket bei Volkswagen... ► Artikel lesen | |
| SANARA MEDTECH | 34,740 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,790 | +0,13 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 19,410 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |
ONEMEDNET CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,682 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONEMEDNET CORP finden Sie auf Wallstreet Online.